Evaluación de la correlación la dosis de diálisis (Kt/V) y el estatus de fragilidad en el paciente crónico dializado
datacite.rights | http://purl.org/coar/access_right/c_16ec | |
dc.contributor.advisor | Aroca Martínez, Gustavo | |
dc.contributor.advisor | Guido Musso, Carlos | |
dc.contributor.author | Hernández Agudelo, Sandra Yolima | |
dc.contributor.author | Maya Altamiranda, Lina Paola | |
dc.date.accessioned | 2020-11-05T22:06:41Z | |
dc.date.available | 2020-11-05T22:06:41Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Introducción: la fragilidad es un síndrome multicausal caracterizado por una disminución de fuerza, resistencia y función fisiológica, lo que hace al individuo vulnerable y dependiente, y aumenta su mortalidad. Este síndrome es más frecuente entre las personas mayores y los pacientes con enfermedad renal crónica, particularmente aquellos en diálisis. La dosis de diálisis está estandarizada actualmente para pacientes en hemodialálisis (HD) independientemente de su edad y estado funcional. Sin embargo, se ha postulado que la dosis de diálisis requerida en pacientes mayores, especialmente los frágiles, debe ser menor, ya que podría aumentar su grado de fragilidad. Entonces, el propósito de este estudio fue evaluar si habría una correlación entre la dosis de Kt / V y el grado de fragilidad en un población de pacientes adultos en HD. Material y métodos: un estudio transversal con 82 pacientes en HD en Barranquilla (Colombia) y Lobos (Argentina). Se registraron datos sociodemográficos y de laboratorio, así como dosis de diálisis (Kt / V) y se aplicaron escalas de fragilidad, actividad física, marcha y fuerza de agarre. Entonces estos los datos se correlacionaron mediante una correlación de Spearman y una regresión logística. Resultados: SFC, aislamiento social, actividad física, velocidad de la marcha y pruebas de fuerza prensil fueron fuera de los rangos de referencia en el grupo estudiado. No se encontró correlación significativa entre la dosis de diálisis y todas las pruebas funcionales mencionadas anteriormente. Sin embargo, fue documentó una correlación significativa e inversa entre la actividad física y el síndrome de fatiga crónica (puntuación -1,41 (IC: -2,1 a -0,7). En conclusión: no hubo correlación significativa documentado entre el valor Kt / V y diferentes parámetros del estado de fragilidad, pero esto el estado se correlacionó de manera significativa e inversa con la actividad física en este grupo. Fragilidad El estado de los pacientes en hemodiálisis fue significativamente mayor en las personas mayores, aunque los jóvenes no estaban exentos de ella. | spa |
dc.description.abstract | Introduction: Frailty is a multicausal syndrome characterized by a decrease in strength, resistance and physiological function, which makes the individual vulnerable and dependent, and increases his/her mortality. This syndrome is more prevalent among older individuals, and chronic kidney disease patients, particularly those on dialysis. Dialysis dose is currently standardized for hemodiallysis (HD) patients regardless their age and functional status. However, it has been postulated that the dialysis dose required in older patients, especially frail ones, should be lower, since it could increase their degree of frailty. Then, the purpose of this study was to evaluate if there would be a correlation between the dose of Kt/V and the degree of frailty in a population of adult patients on HD. Material & methods: A cross-sectional study with 82 patients on HD in Barranquilla (Colombia) and Lobos (Argentina) was conducted. Socio-demographic and laboratory data, as well as dialysis doses (Kt/V) were recorded and scales of fragility, physical activity, gait and grip strength were applied. Then these data were correlated by a Spearman’s correlation and a logistic regression. Results: CFS, social isolation, physical activity, gait speed, and prehensile strength tests were outside the reference ranges in the studied group. No significant correlation was found between dialysis dose and all the above mentioned functional tests. However, it was documented a significant and inverse correlation between physical activity and CFS (score -1.41 (CI: -2.1 to -0.7). In conclusion: no significant correlation was documented between Kt/V value and different parameters of the frailty status, but this status correlated significantly and inversely with physical activity in this group. Frailty status in hemodialysis patients was significantly higher in older individuals, although young individuals were not exempt from it | eng |
dc.format.mimetype | ||
dc.identifier.uri | https://hdl.handle.net/20.500.12442/6769 | |
dc.language.iso | spa | |
dc.publisher | Ediciones Universidad Simón Bolívar | spa |
dc.publisher | Facultad de Ciencias de la Salud | spa |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | eng |
dc.rights.accessrights | info:eu-repo/semantics/restrictedAccess | spa |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | Fragilidad | spa |
dc.subject | Dosis de diálisis | spa |
dc.subject | Hemodiálisis | spa |
dc.subject | Frailty | eng |
dc.subject | Dialysis dose | eng |
dc.subject | Hemodialysis. | eng |
dc.title | Evaluación de la correlación la dosis de diálisis (Kt/V) y el estatus de fragilidad en el paciente crónico dializado | spa |
dc.type.driver | info:eu-repo/semantics/other | |
dc.type.spa | Otros | |
dcterms.references | Proietti M, Cesari M. Frailty: What Is It? 2020. 1–7. doi:10.1007/978-3-030- 33330-0_1 | eng |
dcterms.references | Tabue-Teguo M, Simo N, Gonzalez-Colaço Harmand M, et al. Frailty in elderly: a brief review. Geriatr Psychol Neuropsychiatr Vieil 2017;15:127–37. doi:10.1684/pnv.2017.0670 | eng |
dcterms.references | Cesari M, Calvani R, Marzetti E. Frailty in Older Persons. Clin Geriatr Med 2017;33:293–303. doi:10.1016/j.cger.2017.02.002 | eng |
dcterms.references | Cesari M, Marzetti E, Thiem U, et al. The geriatric management of frailty as paradigm of ‘The end of the disease era’. Eur J Intern Med 2016;31:11–4. doi:10.1016/j.ejim.2016.03.005 | eng |
dcterms.references | Cesari M, Prince M, Thiyagarajan JA, et al. Frailty: An Emerging Public Health Priority. J Am Med Dir Assoc 2016;17:188–92. doi:10.1016/j.jamda.2015.12.016 | eng |
dcterms.references | Lee L, Heckman G, Molnar FJ. Frailty: Identifying elderly patients at high risk of poor outcomes. Can Fam Physician 2015;61:227– 31.http://www.ncbi.nlm.nih.gov/pubmed/25767167 | eng |
dcterms.references | Won CW. Frailty: Its Scope and Implications for Geriatricians. Ann Geriatr Med Res 2019;23:95–7. doi:10.4235/agmr.19.0032 | eng |
dcterms.references | Cesari M, Vellas B. Frailty in Clinical Practice. Nestle Nutr Inst Workshop Ser 2015;83:93–8. doi:10.1159/000382091 | eng |
dcterms.references | Morley JE, Vellas B, van Kan GA, et al. Frailty consensus: a call to action. J Am Med Dir Assoc 2013;14:392–7. doi:10.1016/j.jamda.2013.03.022 | eng |
dcterms.references | Cesari M, Vellas B, Gambassi G. The stress of aging. Exp Gerontol 2013;48:451–6. doi:10.1016/j.exger.2012.10.004 | eng |
dcterms.references | Henchoz Y, Büla C, Guessous I, et al. Association between Physical Frailty and Quality of Life in a Representative Sample of Community-Dwelling Swiss Older People. J Nutr Health Aging 2017;21:585–92. doi:10.1007/s12603- 016-0772-4 | eng |
dcterms.references | Clegg A, Young J, Iliffe S, et al. Frailty in elderly people. Lancet (London, England) 2013;381:752–62. doi:10.1016/S0140-6736(12)62167-9 | eng |
dcterms.references | Subra J, Gillette-Guyonnet S, Cesari M, et al. The integration of frailty into clinical practice: preliminary results from the Gérontopôle. J Nutr Health Aging 2012;16:714–20. doi:10.1007/s12603-012-0391-7 | eng |
dcterms.references | Proietti M, Cesari M. Frailty: What Is It? Adv Exp Med Biol 2020;1216:1–7. doi:10.1007/978-3-030-33330-0_1 | eng |
dcterms.references | Mendiratta P, Latif R. Clinical Frailty Scale. 2020. http://www.ncbi.nlm.nih.gov/pubmed/32644435 | eng |
dcterms.references | Rockwood K, Song X, MacKnight C, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ 2005;173:489–95. doi:10.1503/cmaj.050051 | eng |
dcterms.references | Duke D. Measuring frailty in geriatric patients. CMAJ 2006;174:352–3; author reply 353. doi:10.1503/cmaj.1050199 | eng |
dcterms.references | Woo J, Leung J, Morley JE. Comparison of frailty indicators based on clinical phenotype and the multiple deficit approach in predicting mortality and physical limitation. J Am Geriatr Soc 2012;60:1478–86. doi:10.1111/j.1532- 5415.2012.04074.x | eng |
dcterms.references | Rockwood K, Theou O. Using the Clinical Frailty Scale in Allocating Scarce Health Care Resources. Can Geriatr J 2020;23:210–5. doi:10.5770/cgj.23.463 | eng |
dcterms.references | Lemus-Barrios GA, Morales-Benavidez DC, López-Salazar AM, et al. Evaluación de la fragilidad en la enfermedad cardiovascular: Un reto necesario | Assessment of frailty in cardiovascular disease: A necessary challenge. Rev Colomb Cardiol 2020;27:283–93. doi:10.1016/j.rccar.2019.12.015 | eng |
dcterms.references | Hatheway OL, Mitnitski A, Rockwood K. Frailty affects the initial treatment response and time to recovery of mobility in acutely ill older adults admitted to hospital. Age Ageing 2017;46:920–5. doi:10.1093/ageing/afw257 | eng |
dcterms.references | Theou O, Squires E, Mallery K, et al. What do we know about frailty in the acute care setting? A scoping review. BMC Geriatr 2018;18:139. doi:10.1186/s12877-018-0823-2 | eng |
dcterms.references | Pulok MH, Theou O, van der Valk AM, et al. The role of illness acuity on the association between frailty and mortality in emergency department patients referred to internal medicine. Age Ageing 2020;49:1071–9. doi:10.1093/ageing/afaa089 | eng |
dcterms.references | Lang P-O, Michel J-P, Zekry D. Frailty syndrome: a transitional state in a dynamic process. Gerontology 2009;55:539–49. doi:10.1159/000211949 | eng |
dcterms.references | Li H, Manwani B, Leng SX. Frailty, inflammation, and immunity. Aging Dis 2011;2:466–73.http://www.ncbi.nlm.nih.gov/pubmed/22396895 | eng |
dcterms.references | Vatic M, von Haehling S, Ebner N. Inflammatory biomarkers of frailty. Exp Gerontol 2020;133:110858. doi:10.1016/j.exger.2020.110858 | eng |
dcterms.references | Wang GC, Casolaro V. Immunologic changes in frail older adults. Transl Med @ UniSa 2014;9:1–6.http://www.ncbi.nlm.nih.gov/pubmed/24809027 | eng |
dcterms.references | Aiello F, Dueñas E, Musso C. Senescent Nephropathy: The New Renal Syndrome. Healthcare 2017;5:81. doi:10.3390/healthcare5040081 | eng |
dcterms.references | Musso CG, Jauregui JR, Macías Núñez JF. Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol 2015;47:1801–7. doi:10.1007/s11255-015-1112-z | eng |
dcterms.references | Aatif T, Hassani K, Alayoud A, et al. Quantification of Hemodialysis Dose: What Kt/V to Choose? Int J Artif Organs 2014;37:29–38. doi:10.5301/ijao.5000236 | eng |
dcterms.references | Musso CG, Schwartz P, Deira J, et al. Is It Correct to Use a Unique Conventional Dialysis Prescription in the Elderly? Four Alternative Schedules for Dialyzing Elderly Patients. Int J Ren Dis Ther 2018;1. doi:10.31021/ijrdt.20181103 | eng |
dcterms.references | Musso CG, Vilas M. Nephroprevention in the very old patient. Rev Colomb Nefrol 2015;2:131–6. doi:10.22265/acnef.2.2.213 | eng |
oaire.version | info:eu-repo/semantics/submittedVersion | |
sb.programa | Especialización en Medicina Interna | spa |
sb.sede | Sede Barranquilla | spa |